Search

Search Constraints

You searched for: Author/Creator Koike, Ryuji

Search Results

1. A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and Japan. Issue 4 (July 2014)

2. Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategy. Issue 5 (3rd September 2017)

3. An adult case of suspected A20 haploinsufficiency mimicking polyarteritis nodosa. (20th May 2022)

4. An open-label, randomized controlled trial of sulfamethoxazole–trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up. Issue 2 (6th July 2020)

5. Anti-MDA5 antibody–positive dermatomyositis with rapidly progressive interstitial lung disease disguising as anti-synthetase syndrome. (24th October 2020)

6. Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nationwide Consortium to Investigate Host Genetics of COVID-19. (December 2021)

7. Clinical significance of prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID‐19: Integrative analysis from the Japan COVID‐19 task force. Issue 1 (26th September 2022)

9. Diagnostic significance of secondary bacteremia in patients with COVID-19. Issue 4 (April 2023)

10. Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules. Issue 11 (13th April 2012)